Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC7A6 |
| Upstream (Parents) |
|---|
| (<<) MYB → SLC7A6 |
| (<<) VDR → SLC7A6 |
| Downstream (Children) |
|---|
| SLC7A6 → UBL3 (>>) |
| SLC7A6 → ME3 (>>) |
| SLC7A6 → LY75 (>>) |
| SLC7A6 → FLJ20712 (>>) |
| SLC7A6 → NPEPL1///STX16 (>>) |
| SLC7A6 → H2AFJ (>>) |
| SLC7A6 → ASAP1IT1 (>>) |
| SLC7A6 → ZNF37B (>>) |
| SLC7A6 → UNKL (>>) |
| SLC7A6 → SUN1 (>>) |
| SLC7A6 → MARS (>>) |
| SLC7A6 → C15orf5 (>>) |
| SLC7A6 → FAM105A (>>) |
| SLC7A6 → HSPA1L (>>) |
| SLC7A6 → RGS14 (>>) |
| SLC7A6 → KIF21B (>>) |
| SLC7A6 → TRAF5 (>>) |
| SLC7A6 → ARSF (>>) |
| SLC7A6 → ROPN1B///ROPN1 (>>) |
| SLC7A6 → MID1 (>>) |
| SLC7A6 → LOC595101///BOLA2///LOC440354 (>>) |
| SLC7A6 → LOC729143///MPRIP (>>) |
| SLC7A6 → MED13L (>>) |
| SLC7A6 → KIAA1609 (>>) |
| SLC7A6 → WDR60 (>>) |
| SLC7A6 → KIAA1009 (>>) |
| SLC7A6 → PLXNA1 (>>) |
| SLC7A6 → CYP27B1 (>>) |
| SLC7A6 → SLC26A1 (>>) |
| SLC7A6 → COX4I1 (>>) |
| SLC7A6 → GOLGA1 (>>) |
